Lymphocyte Activation and Differentiation
eBook - PDF

Lymphocyte Activation and Differentiation

Fundamental and Clinical Aspects. Proceedings of the 18th International Leucocyte Culture Conference. La Grande Motte, France, June 19–24, 1987

  1. 981 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Lymphocyte Activation and Differentiation

Fundamental and Clinical Aspects. Proceedings of the 18th International Leucocyte Culture Conference. La Grande Motte, France, June 19–24, 1987

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Lymphocyte Activation and Differentiation by J. C. Mani, J. Dornand in PDF and/or ePUB format, as well as other popular books in Medicine & Hematology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
De Gruyter
Year
2019
Print ISBN
9783110107609
eBook ISBN
9783110850253
Edition
1
Subtopic
Hematology

Table of contents

  1. PREFACE
  2. CONTENTS
  3. INTRODUCTION
  4. Fundamental and Clinical Aspects of Lymphocyte Activation and Differentiation
  5. PLENARY LECTURE
  6. Oncogenes and Multistep Carcinogenesis
  7. SYMPOSIA BIOCHEMICAL AND CELLULAR ASPECTS OF LYMPHOCYTE ACTIVATION
  8. Biochemical and Molecular Events Controlled by Lymphoid and Myeloid Growth Factors
  9. PGE2 Inhibition of Human T Lymphocytes Proliferation: Regulatory Effect of PGE2 on the Intra-Cellular Signaling Pathways
  10. Structure-Function Relationships for the Interleukin 2 Receptor
  11. Monovalent Cation Fluxes as Regulators of Critical Nuclear Events in Lymphocyte Activation: Mirror Image Processes in Differentiation and Proliferation
  12. Diacylglycerol, Calcium, cAMP and cGMP Mediate Qualitatively Distinct Protein Kinase C Translocation Events in Normal B Lymphocytes
  13. Phosphorylation of Prosolin and Leucocyte Growth Regulation
  14. DIFFERENTIATION OF T AND B LYMPHOCYTES
  15. Regulation of Human B Cell Function
  16. The Role of Lymphokines in the Immunoglobulin Class Switch
  17. Mouse and Human B Cell Activating Factors
  18. Molecular Cloning of the Murine T11 (CD2) cDNA
  19. Antigen Expression and Proliferative Activity during B and T Cell Development
  20. MOLECULAR BIOLOGY OF LEUCOCYTES (ANTIGENS, RECEPTORS, INTERLEUKINS)
  21. The Molecular Biology of the Multisubunit Interleukin-2 Receptor
  22. Expression and Rearrangement of T Cell Receptor Genes in Human Leukemic T Cell Lines
  23. The Human T-Cell Rearranging γ Genes (TRGγ)
  24. Immunoglobulin Gene Expression
  25. Structure and Expression of Mouse Fcy Receptor II (FcyRII)
  26. VIRUS-INDUCED LYMPHOCYTE DYSFUNCTIONS
  27. The Impact of the Presence of EBV on the Interaction of B Cell Lines with T Lymphocytes
  28. Induction of B Cell Activation Markers by Epstein-Barr Virus
  29. Production of Interleukin-1 (IL1) by EBV-Infected Cells
  30. DNA-Mediated Gene Transfer of Epstein-Barr Virus Receptor onto Murine Fibroblasts
  31. ACCESSORY CELL FUNCTIONS
  32. Modulation of IL1 Receptor Expression by IL1, Prostaglandins and Glucocorticoids
  33. Tumor Necrosis Factors: Modulation of Synthesis and Biological Activities
  34. Analysis of the Structure and Function of Immunectin
  35. Natural Effector Cells of the Intestinal Epithelium: Ontogeny, Function, and Regulation
  36. Analysis of Ia-Transfected Fibroblasts: Antibody and T Cell Recognition Sites Segregate with the 31 Domain of the E3 Polypeptide Chain
  37. WORKSHOPS WORKSHOP A. GROWTH AND DIFFERENTIATION FACTORS
  38. Inhibition by Cyclosporin A of the IL2 Dependent Autocrine Growth in a Human Tumor T Cell Line and Fate of IL2 Receptors after Endocytosis
  39. Interleukin B, a B Cell-Derived Lymphokine
  40. Induction and Enhancement of Lymphokine Gene Expression in Human T Cell Clones Transfected with HTLV-I pX cDNA
  41. Evidence for a Human B Cell Activating Factor Acting on Resting B Lymphocytes
  42. Splicing Intermediates of the IL-2 Receptor (p55 Subunit)
  43. The Role of Plasminogen Activator in Regulating T Cell Proliferation and Interferon Production
  44. Membrane and Soluble IL2-R Produced by Human T Cell Clones: A Comparative Study
  45. Phenotype and Cytokines Production by Human Myeloma Cell Lines
  46. B + Null Cell-Derived Prothymocyte Differentiating Activity (PTDA): Biological Properties and Physicochemical Characterization
  47. TDM-Activated Macrophages Produce a Cytostatic Factor Distinct from TNFα, IFNα,β, and IL-1
  48. Characterization of a Factor Produced by Human Alloreactive T Cell Clones
  49. WORKSHOP B. MECHANISMS OF AUTOIMMUNITY
  50. Effector Mechanisms of Autoimmune Diseases
  51. T Cell Response to Myelin Basic Protein in Healthy Subjects and Multiple Sclerosis Patients
  52. Active T Cell Regulation of Autoimmune Responses in Autoimmune and "Nonautoimmune" Spleen Cell Populations
  53. Interleukin-2 Receptor Targeted Immunotherapy of Autoimmune Diseases: Treatment Strategies for Type I Diabetes
  54. Protection of Non-Obese Diabetic (NOD) Mice from Insulitis by Neonatal Injection of F<sub>1</sub> Spleen Cells
  55. WORKSHOP C. ONCOGENES AND LEUCOCYTE TRANSFORMATION
  56. Complex Transcriptional Regulation of Nuclear Proto Oncogenes: Existence of a Block to Elongation in C-Myc and C-Fos Genes
  57. Determinants of C-Fos and C-Myc mRNAs Instability
  58. Cloning and Functional Analysis of the Human C-fms Gene
  59. Effects of Proliferative (Interleukin, Colony Stimulating Factors) and Antiproliferative (Cyclic AMP, Interferon) Signals on Gene Expression in Myeloid and Lymphoid Cell Lines
  60. The Progession to Tumourigenes is Following Transformation of Murine Myelomonocytic Cell by V-Myc
  61. HTLV-I Infection of a Human Antigen Specific Proliferating/Cytotoxic T Cell Clone Results in a Loss of Cytotoxicity but does not Affect the T Cell Receptor
  62. WORKSHOP D. EXPERIMENTAL MODELS OF IMMUNOMODULATION
  63. Roles of Monokines in the Nonspecific Host Defence Stimulated by Exogenous Agents
  64. Enhancement of the Immune Response Using a Synthetic B-Lymphocyte Mitogen Covalently Linked to Antigens
  65. Effects of in vivo Treatment of Mice with Anti-Murine T3 Antibody: Suppression of Transplantation Responses
  66. Gamma-Interferon Protects Listeria-Susceptible BALB/c Mice from Lethal Listeriosis without Affecting the Development of Protective Immunity
  67. Effect of a Lipophilic Muramylitri peptide on Gamma-Interferon Induced Major Histocompatibility Antigen (MHC) and Leu-M3 Antigen Changes in Human Monocytes
  68. Effect of Cyclosporin A (CsA) on the Induction of Memory T Lymphocytes
  69. Modulation by Cyclosporin A (CsA) of the Immune System of Mice Infected with Lymphocytic Choriomeningitis Virus (LCMV)
  70. Modulation of Lymphocyte Activation in vitro by a Soluble Placental Factor
  71. The Role of Interleukins and the Interleukin-2 Receptor in the Pathogenesis of Murine Cutaneous Leishmaniasis
  72. In vitro Studies of Synthetic Glycolipids: A New Class of Compounds with Immunomodulating Activity
  73. Immunotoxicity Studies of PCB (Aroclor 1254) in the Adult Rhesus (Macaca mulatta) Monkey
  74. Human Cytomegalovirus Induces Alterations in Mixed Lymphocyte Reactions
  75. WORKSHOP E. IMMUNODEFICIENCIES
  76. Immunological Aspects of AIDS and HIV Infection
  77. Studies Regarding the Interaction of the T4 (CD4) Molecule with the Envelope Protein gp120 of the Human Immunodeficiency Virus (HIV)
  78. Low Level Re-Expression of the Silent MHC Class-II Genes in the Lymphoblasts from Patients with the HLA-Class II Deficient SCID
  79. Adenylate Cyclase and 5'Nucleotidase Activities of Peripheral Blood Mononuclear Cells is Psoriasis
  80. WORKSHOP F. NATURAL KILLER CELLS
  81. Natural Killer Cells
  82. Characterization and Population Kinetics of Liver-Associàted Large Granular Lymphocytes (Natural Killer Cells)
  83. Modulation of Lymphonkine Activated Killer Activity of Lymphocytes Isolated from Human Peripheral Blood and Bone Marrow by Recombinant IL4
  84. Inhibition of Human Natural Killer Cells by Resistant Target Cells
  85. Changes in Gene Expression Associated with Activation or Inhibition of Natural Killer Function
  86. Fibronectin Expression by Endogenous and Activated NK Cells
  87. Cytolytic Potential of CD3<sup>+</sup>4<sup>-</sup>8<sup>-</sup> T Cells with Differently Organized T Cell Receptor Y Chains
  88. WORKSHOP G, DIFFERENTIATION AND ACTIVATION OF T LYMPHOCYTES
  89. CD1a Molecules Form Intermolecular Complexes with HLA Class I Molecules or Other CD1 Molecules on Normal Human Thymus Cells
  90. The CD2 Pathway of Activation. Epitope Requirements, Linkage to Other Surface Molecules and Early Biochemical Events
  91. A T-Cell Surface Molecule Different from CD2 is Involved in Spontaneous Rosette Formation with Erythrocytes
  92. A Dual Function of the T4 Molecule in the Cytolytic Activity of Human T Cell Clones
  93. Role of Antigen-Specific T Cell Receptor and Associated Proteins in the Activation of a Cytolytic T Cell Clone Analysed by Protein Phosphorylation and by T Cell Receptor Negative Variants
  94. Y-Chain T Cell Receptors on Denoritic Epidermal Cells
  95. Stimulation of T Cells via LY-6C: A Phssphatidylinositol-Anchored Cell Surface Molecule which Generates Intracellular Calcium Mobilization upon Cross-Linking
  96. New Subgroups in the Human T Cell Rearranging VΓ Gene Locus
  97. Genomic Organisation of the Constant Regions of the Human T-Cell Rearranging Gene Γ
  98. Second Signals for T Cell Mitogenesis Provided by a MAbs CD45 (T200) and CD5 (T1)
  99. WORKSHOP H. DIFFERENTIATION AND ACTIVATION OF B LYMPHOCYTES
  100. Immunobiology of B Lymphocytes
  101. Regulation of B Lymphocyte Responsiveness by Multiple Cytokines
  102. Influence of IL4 on the Induction of Immunoglobulin Secretion by BCAF-Containing Supernatant
  103. Early B Cells Immortalized by Epstein-Barr Virus (EBV) - A Phenotypic Study
  104. The Human B Cell Repertoire: Multispecificity as a Major Characteristic of Antibodies Secreted by Human EBV-Transformable Cord Blood B Cells
  105. Analysis of Excessive B Cell Growth in Lymph Nodes of L. major Infected Mice: The Effect of L. major Specific T-Cell Clones
  106. Antibody Response in vitro of Human Peripheral Blood Lymphocytes: Application of a Limiting Dilution Method
  107. Frequency Analysis of Functional Immunoglobulin C<sub>E</sub> Gene Expression in LPS-Reactive Murine B Cells
  108. Changes in Gene Expression in Differentiating B Lymphocytes
  109. Regulation of Lipopolysaccharide (LPS)-Induced B Cell Differentiation by Ly-5 and Uyb-2 Molecules
  110. WORKSHOP I. LIPIDIC MEDIATORS OF THE IMMUNE RESPONSE
  111. Phospholipid-Derived Mediators and the Immune Response
  112. Anti-Oxidants and IL2 Synthesis
  113. Role of Lipoxygenase Pathway Products in IL2 Synthesis
  114. Platelet Activating Factor (PAF) Induces Human Suppressor Cell Activity
  115. PAF-Acether Induces an Enhanced Release of Interleukin-1 (IL-1) from Human Monocytes
  116. Down-Regulation of CD2 and CD3 Antigen Expression by PAF-Acether
  117. WORKSHOP J. NEURAL MODULATION OF IMMUNITY
  118. Neuroendocrine Modulation of Immunity
  119. Cyclic AMP Response to Dopamine in the Human Monocyte-Like Cell Line U-937
  120. ß-Endorphin Inhibits Thy-1 Antigen Expression on Murine Thymocytes and Antagonizes Thymosin Fraction V Action
  121. WORKSHOP K. BIOCHEMISTRY OF LEUCOCYTE STIMULATION AND EFFECTOR MECHANISMS
  122. Genes Preferentially Expressed in Cytolytic T Cells
  123. Signal Transduction in Lymphocyte Activation
  124. IL-2 Mediated Induction of Lytic Granules, Perforin, and BLT-Esterase in Potent, Granule-Free Cytolytic T Lymphocytes Indicates an Alternative Function of Lytic Granules
  125. Extracel1ular ATP Initiates the Proliferative Response of PMA-Activated Medullary Thymocytes by Increasing their Cytosolic Free Calcium Concentration
  126. Evidence for a Kinase Cascade Stimulated by Interleukin 2 in Cytotoxic T Cell Clones
  127. The Regulation of Cytoskeletal Protein Gene Expression in Lymphocytes
  128. Protein Phosphorylation During T Cell Activation
  129. Clues to Mechanisms of Activation for Killing from the Observations of Changes in Intracellular (Ca<sup>++</sup>) in Individual Cytolytic T Cells and Targets
  130. Induction of Activation Signals in Human T Lymphocytes
  131. Both Lyt2<sup>+</sup> and L3T4<sup>+</sup> Cell Subsets Secrete the Serine Esterase Granzyme A in Response to a Specific Antigenic Stimulus
  132. WORKSHOP L. ACCESSORY CELLS-LYMPHOCYTE INTERACTIONS
  133. Accessory Cells-Lymphocyte Interactions
  134. A Role for HLA-Class I Molecules from Accessory Cells in T-Cell Activation
  135. Adhesion Molecules of Monocytes
  136. Cellular and Molecular Basis of Self-Induced Proliferation of T Lymphocytes (SIPofT)
  137. Human T Cell Activation: Participation of T Cell Differentiation Antigen Cluster 2 (CD2) in the Generation and/or Transduction of Accessory Cell Signals
  138. WORKSHOP PI. IDIOTYPIC REGULATION
  139. The Influence of Vk Gene Polymorphism on the Induction of Silent Idiotypes in the Arsonate System
  140. Allogeneic Manipulation of the "GAT" Idiotypic Cascade does not Influence the VH Gene Usage
  141. Specific Suppression of the Primary Antibody Response with Immune Complexes Formed in Antibody Excess Depends on the Idiotype and the Isotype of the Antibody Forming the Complex
  142. The HLA-Restricted Presentation of Idiotype to Human Anti-Idiotypic T Cell Clones does not Require Processing by Antigen Presenting Cells
  143. Idiotypic Predominance Alteration in Anti-Arsonate Response by Priming with Anti-Idiotypic Antibodies
  144. Anti-Idiotype Induction of Humoral Immunity in Cattle
  145. Anti MHC-Receptor Cytotoxic T Lymphocytes: Their Role in the Specific Resistance to Graft-Versus-Host Reaction
  146. Altered Anti-Idiotype Response to a(1-3)Dextran-Associated Idiotypes in Mice Bearing an X-Linked Immune Defect
  147. WORKSHOP N. COMPLEMENT RECEPTORS
  148. Human CD3 Complement Receptors
  149. Influence of Antigen-Bound Complement Components C3b and C4b in Activation of Human T-Cell Clones
  150. Human C3 and C3dg Stimulate Proliferation of a Pre-B Lymphoblastoid Cell Line via CR2 Complement Receptor
  151. Activation of B Lymphocytes by Zymosan-Bound C3 Fragments
  152. Contribution of C3 Fragments to Lymphocyte Mediated Lysis of CR2 Carrying Cells
  153. "In vivo" and "in vitro" Modulation of CR1 (C3b Receptor) Expression by its Ligand C3b
  154. WORKSHOP O. MAJOR HISTOCOMPATIBILITY COMPLEX
  155. MHC in Leucocyte Biology
  156. HLA Class I α1, α2, and ß2-Microglobulin Domain Interactions
  157. Diversity and Function of Human Class II MHC Antigens
  158. DRα-DQß Mismatched Isotype Pairing Occurs in EBV Transformed B Cell Lines
  159. Distinct Epitopes for K<sup>d</sup>-Restricted Cytolytic T Cells Specific for HLA-CW3 or HLA-A24 Map to the same Region of HLA
  160. Resistance or Susceptibility of Human Target Cells to NK Lysis: Correlation with the Surface Expression of HLA Class I Molecules and Induction of Susceptibility by Monoclonal Anti Class I Antibodies
  161. WORKSHOP P (SANOFI). CLINICAL APPLICATIONS OF ANTILEUCOCYTE MONOCLONAL ANTIBODIES
  162. Anti-Leucocyte Monoclonal Antibodies: From Laboratory Reagents to Therapeutic Agents
  163. Treatment of Donor Bone Marrow with FabT101 Ricin A-Chain Immunotoxin for the Prevention of Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation
  164. Monoclonal Antibodies for Bone Marrow Purging before Transplantation: A Brief Review
  165. Comparative Efficiency of an Immunomagnetic Purging Procedure and a Rabbit Complement Lysis to Eliminate BL Cells from the Bone Marrow
  166. In vivo Antigenic Modulation of CD5<sup>+</sup> Cells in Renal Transplanted Patients Receiving Anti-CD5 Antibody Infusions
  167. In vivo Therapy by CD8 Monoclonal Antibody for Delays to Hematological Recovery after Autologous Bone Marrow Transplantation
  168. Autologous Bone Marrow Transplantation for Acute Lymphoblastic Leukemia in Remission. In vitro Purging of Inoculum with Monoclonal Antibodies and Complement
  169. Immunosuppression by Murine Monoclonal Antibodies: The Rhesus Monkey Used for Preclinical Testing
  170. Therapeutic Applications of Monoclonal Antibodies for Lymphoma and Leukemia
  171. BMA 031 - The TCR Specific Monoclonal Antibody for Clinical Applications
  172. Immunoassays for the Monitoring of Kidney Graft's Transplanted Patients under 33B3.1 MOAB Therapy
  173. Prospective Randomized Studies of T Cell Depletion in HLA Matched Bone Marrow Transplantation (BMT) for Leukemia: 2 Studies of the GEGMO in 92 Patients
  174. A Monoclonal Anti Interleukin 2 Receptor Prevents Human Kidney Graft Rejection
  175. Clinical Pharmacology of 0KT3
  176. Introduction to the Clinical Use of Monoclonal Antibodies as Immunosuppressive Agents
  177. General Considerations on the Quality Control of Monoclonal Antibodies before Therapeutic Use in Man
  178. Immunotoxins with Therapeutic Use in Man
  179. AUTHOR INDEX
  180. SUBJECT INDEX